0001225208-12-024738.txt : 20121206
0001225208-12-024738.hdr.sgml : 20121206
20121206164954
ACCESSION NUMBER: 0001225208-12-024738
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20121201
FILED AS OF DATE: 20121206
DATE AS OF CHANGE: 20121206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carruthers Wendy
CENTRAL INDEX KEY: 0001563565
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 121247192
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
3
1
doc3.xml
X0206
3
2012-12-01
0
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001563565
Carruthers Wendy
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
SVP, Human Resources
Common Stock
32505.0000
D
Deferred Stock Units
2013-02-12
Common Stock
2639.0000
D
Deferred Stock Units
2015-02-16
Common Stock
13077.0000
D
Deferred Stock Units
2014-02-24
Common Stock
6024.0000
D
Deferred Stock Units
2017-02-27
Common Stock
23089.0000
D
Deferred Stock Units
2016-02-28
Common Stock
11172.0000
D
Stock Option (Right to Buy)
7.4700
2015-03-07
2021-03-07
Common Stock
29412.0000
D
Stock Option (Right to Buy)
7.7400
2014-02-26
2020-02-26
Common Stock
8769.0000
D
Stock Option (Right to Buy)
8.3000
2013-02-24
2019-02-24
Common Stock
33512.0000
D
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 12, 2009, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 12, 2008, which will continue to vest in one remaining installment on the anniversary of the date of grant.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 16, 2010, which will continue to vest in three equal annual installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 24, 2009, which will continue to vest in two equal annual installments on the anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
This amount represents the unvested portion of DSUs awarded on February 28, 2011, which will continue to vest in four equal annual installments on the anniversary of the date of grant.
Grant to the reporting person of an option to purchase 29,412 shares of common stock vesting in whole on March 7, 2015, the fourth anniversary of the grant.
Grant to the reporting person of an option to purchase 8,769 shares of common stock vesting in whole on February 26, 2014, the fourth anniversary of the grant.
Grant to the reporting person of an option to purchase 33,512 shares of common stock vesting in whole on February 24, 2013, the fourth anniversary of the grant.
poacarruthers.txt
/s/ Conor Kilroy, Attorney-in-Fact
2012-12-06
EX-99
2
poacarruthers.txt
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes and appoints
each of Timothy A. Pratt, Vance R.
Brown, Theresa R. Boni, Todd D. Hammond and Conor Kilroy signing singly, the
undersigned's true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or
director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5, and
amendments thereto, in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to
complete and execute any such Form 3, 4 or 5 and file such form with the United
States Securities and Exchange
Commission and any stock exchange or similar authority;
(3) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or
director of the Company, Forms 144 in accordance with Rule 144 of the Securities
Act of 1933, as amended, and
the rules and regulations thereunder; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and
every act and thing whatsoever requisite, necessary, or proper to be done in the
exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of
attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming,
any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 or Rule
144 of the Securities Act of 1933, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file
Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and
transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 30th day
of November, 2012.
/s/ Wendy Carruthers
Wendy Carruthers